IRD Stock Summary and Trading Ideas (Opus Genetics | NASDAQ:IRD)

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA), and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

What symbol and exchange does Opus Genetics shares trade?

Opus Genetics trades on the NASDAQ stock market under the symbol IRD.

What is Opus Genetics stock price doing today?

As of December 29, 2025, IRD stock price declined to $1.99 with 326,257 million shares trading.

What is Opus Genetics's Beta?

IRD has a beta of 0.97, meaning it tends to be less sensitive to market movements. IRD has a correlation of 0.04 to the broad based SPY ETF.

How much is Opus Genetics worth?

IRD has a market cap of $137.24 million. This is considered a Micro Cap stock.

How much money does Opus Genetics make?

Last quarter Opus Genetics reported $3 million in Revenue and -$.25 earnings per share. This beat revenue expectation by $121,002 and missed earnings estimates by -$.12.

What are the top ETFs holding Opus Genetics?

The top ETF exchange traded funds that IRD belongs to (by Net Assets): VTI, VXF, BSVO.

Is Opus Genetics (IRD) a good investment?

IRD has outperformed the market in the last year with a return of +84.3%, while the SPY ETF gained +15.7%. In the last 3 month period, IRD beat the market returning +9.3%, while SPY returned +4.3%. However, in the most recent 2 weeks IRD has underperformed the stock market by returning -15.7%, while SPY returned +1.2%.

What are the support and resistance levels for Opus Genetics (IRD)?

IRD support price is $1.93 and resistance is $2.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IRD shares will trade within this expected range on the day.